NASDAQ:IBB iShares Biotechnology ETF (IBB) Price, Holdings, & News $143.00 +0.82 (+0.58%) (As of 10/8/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrends About iShares Biotechnology ETF (NASDAQ:IBB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBB alerts:Sign Up Key Stats Today's Range$141.99▼$143.3850-Day Range$138.19▼$149.4752-Week Range$111.83▼$150.57Volume608,470 shsAverage Volume1.49 million shsMarket Capitalization$7.46 billionAssets Under Management$7.32 billionDividend Yield0.31%Net Expense Ratio0.45%Aggregate RatingModerate Buy ETF OverviewiShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Read More… [SHOCKING] Crypto Document Leak… (Ad)The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.Download your digital copy now iShares Biotechnology ETF ExpensesTypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.45%0.56%0.55%0.49%0.52%Other Expenses0.00%0.33%0.49%0.41%0.54%Total Expense0.45%0.71%0.70%0.63%0.71%Fee Waiver0.00%-0.45%-0.52%-0.33%-0.58%Net Expense0.45%0.61%0.61%0.56%0.59% Receive IBB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBB ETF News HeadlinesBiotech Boom Ahead? Key Stocks and ETFs to Watch Now (IBB)The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.September 23, 2024 | marketbeat.comBiotech Breakout: Stocks for Your WatchlistThe iShares Biotechnology ETF (IBB) has turned $140 resistance into support, positioning the overall sector for a potential breakout above $150.September 12, 2024 | marketbeat.com[SHOCKING] Crypto Document Leak…The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.October 8, 2024 | Crypto 101 Media (Ad)iShares Biotechnology ETF (NASDAQ:IBB) Short Interest Down 8.6% in SeptemberOctober 1, 2024 | americanbankingnews.comWatch the Long Bonds for Any Signs of Risk-Off SentimentSeptember 26, 2024 | investing.comiShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.2005September 25, 2024 | msn.comSee More Headlines IBB ETF - Frequently Asked Questions How have IBB shares performed this year? iShares Biotechnology ETF's stock was trading at $135.85 at the start of the year. Since then, IBB shares have increased by 5.3% and is now trading at $143.00. View the best growth stocks for 2024 here. When did iShares Biotechnology ETF's stock split? Shares of iShares Biotechnology ETF split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were payable to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. Who are iShares Biotechnology ETF's major shareholders? Top institutional shareholders of iShares Biotechnology ETF include Appleton Partners Inc. MA (0.14%), Chesley Taft & Associates LLC (0.06%), Mirador Capital Partners LP (0.06%) and Perkins Coie Trust Co (0.05%). How do I buy shares of iShares Biotechnology ETF? Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of iShares Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO) and Micron Technology (MU). Fund Details IssueriShares Fund NameiShares Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkICE Biotechnology Index (TR) (USD) CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings219 Fund Statistics Assets Under Management$7.32 billion Average Daily Volume$1.11 million Discount/Premium-0.03% Administrator, Advisor and Custodian AdministratorJPMorgan Chase Bank, N.A. AdvisorBlackRock Fund Advisors CustodianJPMorgan Chase Bank, N.A. DistributorBlackRock Investments, LLC Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerLatour Trading Options OptionableOptionable Options Volume3,080 Put Options2,458 Call Options622 Short Interest9,300,000 shs Miscellaneous Outstanding Shares52,150,000Beta0.84 Creation Unit50,000 Creation Fee$614.00 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Top 10 IBB HoldingsGilead Sciences (NASDAQ:GILD)Holding Weight: 8.76%Amgen (NASDAQ:AMGN)Holding Weight: 7.82%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 7.61%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 7.17%IQVIA (NYSE:IQV)Holding Weight: 4.06%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 3.35%Mettler-Toledo International (NYSE:MTD)Holding Weight: 3.06%argenx (NASDAQ:ARGX)Holding Weight: 2.71%Biogen (NASDAQ:BIIB)Holding Weight: 2.65%BioNTech (NASDAQ:BNTX)Holding Weight: 2.34%Full Holdings DetailsIBB Sector ExposureIBB Industry Exposure This page (NASDAQ:IBB) was last updated on 10/8/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.